Wang Julia Aijun 的 Form 4/A 修正申報
修正BeOne Medicines Ltd.（ONC），2022/7/18 申報
- 申報編號
- 0001651308-22-000125
- 申報時間
- 2022/7/18
- 交易日
- 2022/7/1
- 申報延遲
- 17 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/7/5
這份申報列了 1 筆非衍生性交易。公開市場賣出合計 $5.02 萬。交易後 17 天申報。
這份修正申報取代了 0001651308-22-000119（2022/7/5 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Wang Julia AijunCIK 0001860279 | 高階主管（財務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/7/1 | American Depositary Shares | S賣出處分 | −317 | $158.50 | −$50,244.5 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on July 1, 2022 as a total of 295 American Depositary Shares ("ADSs") sold when in fact 317 ADSs were sold. As a result of this administrative error, the number of Ordinary Shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of Ordinary Shares reported as beneficially owned by the reporting person by 286 Ordinary Shares.
- F2
Each American Depositary Share represents 13 Ordinary Shares.
- F3
The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.